Secondary Logo

Journal Logo

June 2022 - Volume 45 - Issue 5

  • Steven A. Rosenberg, MD, PhD
  • 1524-9557
  • 1537-4513
  • 9 issues per year
  • Oncology 106/242
    Immunology 73/162
    Medicine, Research, and Experimental 62/140
  • 4.456

Current Issue Highlights


Combination Therapy of an Antibody Specific for Transferrin Receptor 1 (ch128.1/IgG1) With Bortezomib or Lenalidomide Results in Increased Survival in an In Vivo Model of Human Multiple Myeloma: A Brief Communication

Candelaria, Pierre V.; Nava, Miguel; Martínez-Maza, Otoniel; More

Journal of Immunotherapy. 45(5):227-230, June 2022.